Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2010

View Archived Issues

FV-60135-02 ameliorates retinal vascular damage in diabetic rats

SERM GTx-822 prevents oxidative stress

Promising clinical data disclosed on ATI-7505 in CiC

ALKS-27 improves lung function in COPD patients

Promising phase II data presented on NVA-237 in COPD

Pain Therapeutics discovers new mu opioid receptor agonists

New PKD inhibitor CRT-0066101 inhibits pancreatic cell growth

Boston Scientific begins trial to compare Promus Element and Xience Prime stents

Presidio selects HCV NS5A inhibitor PPI-1301 as clinical candidate

CoDa releases phase II efficacy data on Nexagon in venous leg ulcers

Schering claims new gamma-secretase modulators

Wyeth describes new liver X receptor ligands

Bayer Schering identifies new MEK 1 inhibitors

A study of the interactions between dextromethorphan/quinidine, paroxetine and memantine

Interim phase IIa data analysis on Trigemina's TI-001 in chronic daily headache

Vertex reports on phase III ADVANCE trial in HCV infection

GTx reports phase III data on toremifene in prostate cancer

Enrollment opened in phase III Reolysin trial in head and neck cancers

Cytochroma reports phase I/II data on CTAP-101 in CKD-associated hyperparathyroidism

Stem Cell Therapeutics reports on modified REGENESIS stroke trial

OccuLogix changes corporate name to TearLab

FDA approves Lumizyme for late-onset Pompe's disease

FDA grants priority review to Vivitrol sNDA for opioid dependence

Phase IIb trial of Epicept NP-1 in CPN reaches enrollment target

Advanced BioScience and Hawaii Biotech partner on dengue vaccine development

Nippon Boehringer Ingelheim and Astellas extend telmisartan collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...